Lenovo Group Limited (HKSE: 992) (ADR: LNVGY), together with its subsidiaries (‘the Group’), today announced Q3 results for fiscal year 2024/25, reporting significant increases in overall group revenue and profit. Revenue grew 20% year-on-year to US$18.8 billion, marking the third consecutive quarter of double-digit growth. Net income more than doubled year-on-year to US$693 million (including a non-recurring income tax credit of US$282 million) on a Hong Kong Financial Reporting Standards (HKF...

Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive results in recent clinical study. D23 is budesonide delayed-release tablet made by 3D printing using Melt Extrusion Deposition (MED®) process first developed in scale by Triastek based on its proprietary 3D Microstructure for Intestine Targeting (3DμS®-IT) platform. This proprietary platform allows for precise intestinal targeting of drug release and delive...

Address Beach Resort at JBR, renowned for its chic interiors, unmatched comfort, and breathtaking views, redefines luxury hospitality. Just steps from Ain Dubai and home to the world’s highest outdoor infinity pool, this ultra-modern sanctuary offers an unparalleled escape in one of Dubai’s most iconic landmarks. Elevating the guest experience, the resort unveils its elegant Club Rooms and Suites, including the Club Marina City View Room, Club Sea View Room, and Club One Bedroom Executive Sea V...

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced findings published in Transplant International1 that show the performance of AlloSeq™ cfDNA in detecting allograft rejection was consistent with its AlloSure® lab developed test. Kidney allograft rejection is the leading caus...

Spanish pharmaceutical company Ferrer has reaffirmed its status as a B Corp, an international certification awarded to companies that operate with a business model centered on positive impact and meet high social, environmental, and community standards. Ferrer has achieved a score of 136.4 points, making it the highest-rated pharmaceutical company in the world. Additionally, it now ranks as the third-highest scoring company across all sectors globally among those generating more than €500 milli...